Dr Matthew Partridge
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
Latest articles by Dr Matthew Partridge
-
Shake-up at GSK won’t placate investors
News GSK has launched a radical shakeup of its operations, but that's unlikely to satisfy investors unhappy with the drugmaker's perennial underperformance.
By Dr Matthew Partridge Published
News -
Morrisons takeover bid: supermarket is an attractive target for private-equity buyers
News A private-equity group has made an offer for Morrisons, Britain’s fourth-largest supermarket. Other bids are likely to emerge. Matthew Partridge reports.
By Dr Matthew Partridge Last updated
News -
Soho House IPO: celebrities’ hangout hits the market
News Soho House has filed for an initial public offering in New York that values the group at more than $3bn.
By Dr Matthew Partridge Last updated
News -
Investing in stem cells, the building blocks of the body
Cover Story Stem cells have always been tomorrow’s technology. But it looks as though their time has finally come – and they will transform the treatment of disease and drug development, says Matthew Partridge
By Dr Matthew Partridge Last updated
Cover Story -
How to short AMC shares
Tips US cinema chain AMC is the latest meme stock and is now absurdly overvalued, says Matthew Partridge, Here's how to play it.
By Dr Matthew Partridge Last updated
Tips -
Betting on politics: who will win Norway's general election?
Tips Norway is due to go to the polls in a general election in a few months’ time. Matthew Partridge casts his eyes over the candidates and picks a favourite.
By Dr Matthew Partridge Last updated
Tips -
Shell’s fast track to a green-energy future
News Shell, the oil major, has had to accelerate plans to go green, and may now ditch highly profitable assets in America. Matthew Partridge reports
By Dr Matthew Partridge Last updated
News -
Didi Chuxing – “China’s Uber” – arrives for New York stockmarket listed
News Chinese minicab company Didi Chuxing has filed for an initial public offering (IPO) in the US.
By Dr Matthew Partridge Last updated
News -
Anglo American’s coal spin-off Thungela Resources fails to catch fire
News Investors have turned their noses up at Thungela Resources, the London-and-Johannesburg-listed South African coal business spun out of Anglo American
By Dr Matthew Partridge Last updated
News -
A twist in the tale at struggling cinema chain AMC
News American cinema chain AMC may have secured a new lease of life now that it has become the new GameStop. Matthew Partridge reports.
By Dr Matthew Partridge Last updated
News -
Why you should short Tesla, the electric-car maker running on empty
Tips Electric-vehicle maker Tesla is absurdly pricey and faces stiff competition from rivals, says Matthew Partridge. Here’s how to play it.
By Dr Matthew Partridge Last updated
Tips -
Curtain up at Cineworld as lockdown ends, but threats remain
News Cineworld’s shares rose as people returned to cinemas in their droves. But streaming companies such as Netflix and Amazon aren’t standing still. Matthew Partridge reports
By Dr Matthew Partridge Last updated
News -
Credit Suisse’s bankers’ exodus endures
News Senior bankers continue to leave Credit Suisse, after the bank cut the amount of money set aside for employee bonuses.
By Dr Matthew Partridge Last updated
News -
How to invest in the fight against Alzheimer’s disease
Cover Story The cost of caring for those with dementia is a growing problem for healthcare systems around the world. Any firm that develops an effective treatment could stand to make a fortune, reports Matthew Partridge.
By Dr Matthew Partridge Last updated
Cover Story -
A show of support for GlaxoSmithKline's hedge fund fight
News Several large shareholders have said that they will support GlaxoSmithKline in its battle with hedge fund Elliott Management.
By Dr Matthew Partridge Last updated
News -
AT&T ditches media dreams as it spins out WarnerMedia
News Communications group AT&T is spinning off its WarnerMedia business just three years after buying it. Matthew Partridge reports
By Dr Matthew Partridge Last updated
News -
AstraZeneca’s shareholders rebel over pay
News Shareholders in AstraZeneca have rebelled over proposals to raise bonus levels for its bosses.
By Dr Matthew Partridge Last updated
News -
Vaccine patents: a bitter pill for drug companies
News The US has suggested waiving drug companies’ vaccine patents to hasten the defeat of Covid-19, sending their share prices down.
By Dr Matthew Partridge Last updated
News -
BP: really going “beyond petroleum” won't be easy
News BP is recovering and plans to become carbon neutral by 2050. Meanwhile, activist investors are targeting ExxonMobil. Matthew Partridge reports
By Dr Matthew Partridge Last updated
News -
Tate & Lyle to offload its sweeteners division
News Former sugar producer Tate & Lyle is exploring the sale of the part of the firm that produces sweeteners, to focus on its fast-growing food and beverage division.
By Dr Matthew Partridge Last updated
News -
Spreadbetter Plus500 will add to profits – here's how to play it
Tips Plus500, the financial trading platform, surged in lockdown but will also ride the recovery, says Matthew Partridge.
By Dr Matthew Partridge Last updated
Tips -
How to invest as the aviation sector bounces back from Covid-19
Cover Story Shares in airlines have soared over the past few weeks as hopes of a return to normality have risen. Do they have further to climb? And which will do best in the post-pandemic landscape? Matthew Partridge reports
By Dr Matthew Partridge Last updated
Cover Story -
Arm Holdings takeover: has Nvidia had its chips?
News The takeover of Britain’s semiconductor group Arm Holdings by its US rival Nvidia could be running into the sand, says Matthew Partridge.
By Dr Matthew Partridge Last updated
News -
Activist investor Elliott takes takes a stake in Glaxo
News Elliott, s US hedge fund, took an undisclosed multibillion-pound stake in GSK last week, driving the share price up by 4.6%.
By Dr Matthew Partridge Last updated
News